Evidence map›Paper›PMID 35876584›Full record

ArticleMicrobiology spectrum2022

Role of TRAIL-R in Primary and Secondary Genital and Respiratory Chlamydia muridarum Infections in Mice.

Sukumar Pal, Sydni Sheff, Mufadhal Al-Kuhlani, David M Ojcius, Luis M de la Maza

Open access · goldAbstract read
In one paragraph

Article in Microbiology spectrum, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Sukumar PalDepartment of Pathology and Laboratory Medicine, Medical Sciences I, University of California, Irvinegrid.266093.8, Irvine, California, USA.
Sydni SheffDepartment of Pathology and Laboratory Medicine, Medical Sciences I, University of California, Irvinegrid.266093.8, Irvine, California, USA.
Mufadhal Al-KuhlaniDepartment of Biomedical Sciences, Arthur Dugoni School of Dentistry, University of the Pacific, San Francisco, California, USA.
David M OjciusDepartment of Biomedical Sciences, Arthur Dugoni School of Dentistry, University of the Pacific, San Francisco, California, USA.
Luis M de la MazaDepartment of Pathology and Laboratory Medicine, Medical Sciences I, University of California, Irvinegrid.266093.8, Irvine, California, USA.ORCID 0000-0002-6183-7053
University of California, Irvine · USUniversity of the Pacific · US

Funding

Recombinant C. trachomatis vaccineR01AI067888 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI DE LA MAZA, LUIS M · 2007 to 2011
$1.9M
Trapping membrane proteins with adjuvant-carrying amphipols for vaccine formulatiR01AI092129 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI COCCO, MELANIE J, DE LA MAZA, LUIS M · 2011 to 2014
$1.3M
NIAID NIH HHS R01 AI067888NIAID NIH HHS R01 AI092129
6 · The paper itself

Abstract

The tumor necrosis factor (TNF)-related apoptosis-inducing ligand receptor (TRAIL-R) suppresses inflammation and could therefore affect the course of Chlamydia infections and their long-term sequelae. Wild-type (WT) and

Indexed as

Chlamydia InfectionsChlamydia muridarumCoinfectionInfertilityReproductive Tract InfectionsRespiratory Tract InfectionsAnimalsFemaleFibrosisHumansInflammationMaleMiceMice, Inbred C57BLVaginachlamydiaChlamydia muridarumgenital infectionmicerespiratory infectionTNF-related apoptosis inducing ligand receptorTRAIL

Identifiers

PMID35876584
PMCPMC9431660
OpenAlexW4287377424

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.